More on Cholesterol-Lowering Drugs

Post a comment (0 Comments) | Permalink
Last week we learned that many popular cholesterol-lowering drugs fail to deliver. Dr. Fuhrman is no fan of cholesterol medications. Take statins for example:
When resorting to medical intervention, rather than dietary modifications, other problems arise, reducing the potential reduction in mortality possible, as these individuals are at risk of serious side effects from the medication. The known side effects for various statins (the most popular and effective medications to lower cholesterol) include hepatitis, jaundice, other liver problems, gastrointestinal upsets, muscle problems and a variety of blood complications such as reduced platelet levels and anemia.
Now, some doctors have come to the defense of popular medications. Tara Parker-Pope of The New York Times looks at What That Cholesterol Trial Didn’t Show. Here’s a bit:
“I think this study is being interpreted wrong,” said Dr. Paul D. Thompson, director of cardiology at Hartford Hospital, who personally uses Zetia and (like most of the doctors quoted in this article) has consulted with makers of cholesterol drugs.


He pointed out that Vytorin users did experience a larger drop in cholesterol than the Zocor users. The disappointment was that the decline didn’t translate into a bigger benefit in arterial health. “It didn’t show harm,” Dr. Thompson said. “There were no more cardiac events, no more side effects. There was just no change.”

The fallout from the study was not limited to Vytorin. It has led to a whole new set of questions for scientists about cholesterol drugs. Is lowering LDL, the “bad” cholesterol, all that counts? Or must a drug also raise HDL, the “good” cholesterol, and fight inflammation?

Adding to the confusion, the Vytorin makers dragged their feet on releasing the results, issued the findings in a press release rather than a medical journal and made a lot of people mad.
Okay, this makes me ask… Actually, I’ll shut up. Dr. Petrillo was very eager to drop the hammer on this report. Brace yourself, she’s shot out of a cannon! Check it out:
Here's an idea. Stop gorging on cheeseburgers and you won't have to take Zocor or Zetia or Vytorin! Drug reps love to promote these "combo"-type medications with the argument that you're getting two meds for the price of one and attacking the condition in two different ways. But with asparagus as your sword and broccoli as your shield, you will attack high cholesterol without putting expensive drugs with uncertain effects into your body.


According to this recent study, while Vytorin users saw a greater decrease in cholesterol than Zocor users, there was no difference in plaque formation in the coronary arteries between the two groups. Don't just prevent plaque formation! Reverse it by following a high-nutrient-density diet and exercising and you won't need to rely on pills! Cholesterol comes from animal products (even the ads for the cholesterol drugs acknowledge this), so, to avoid blockages in your coronary arteries, fewer animal products, more veggies, less pharmaceuticals, more exercise, less cow, more kale!
“Asparagus as your sword and broccoli as your shield.” Perfect! Especially since I just saw the movie 300—yes, I’m a little behind on the times—here’s the perfect amalgamation of phytonutrients and battle. Enjoy:


This is Sparta! Oops. I mean…these are Phytonutrients!
Post A Comment / Question






Remember personal info?


RedOrbit blog of the day Links Archives